Print this page    •   Back to Web version of article

Prevention/Epidemiology
Shah Congratulates Researchers on PrEP Findings

July 15, 2011

In statement released Thursday, USAID Administrator Rajiv Shah said, "I congratulate the Partners PrEP and CDC TDF2 teams on their study findings demonstrating that PrEP (pre-exposure prophylaxis) -- and HIV medication when taken orally, once a day -- is highly effective in preventing HIV in heterosexual men and women. ... The next step is to determine how these scientific findings can be put to use in real world settings." Through PEPFAR and President Obama's Global Health Initiative (GHI), USAID "is committed to strengthening the response to HIV and will continue to support critical research programs that examine novel approaches to protecting men and women from infection" (7/14).

Back to other news for July 2011


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.



This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/62962/shah-congratulates-researchers-on-prep-findings.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.